Survodutide is an investigational peptide designed to act as a dual agonist at GLP-1 and glucagon receptors. This dual activity is being explored for its synergistic impact on energy expenditure, appetite suppression, and hepatic fat metabolism — making it of growing interest in obesity and metabolic disease research.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
